세계의 조갑진균증 (조백선) 약물 시장예측 2021년-2026년

■ 영문 제목 : Global Onychomycosis (Tinea Unguium) Drug Market Growth (Status and Outlook) 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02117 입니다.■ 상품코드 : LPI-2201K02117
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 114
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,941,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩7,411,500견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩9,882,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 조갑진균증 (조백선) 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (경구약, 외용약)와 용도별 시장규모 (18세 이하, 18~50세, 50세 이상) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 조갑진균증 (조백선) 약물 시장 점유율
- 지역별 조갑진균증 (조백선) 약물 시장규모
- 주요지역의 종류별 시장규모 (경구약, 외용약)
- 주요지역의 용도별 시장규모 (18세 이하, 18~50세, 50세 이상)
- 미주의 조갑진균증 (조백선) 약물 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 조갑진균증 (조백선) 약물 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 조갑진균증 (조백선) 약물 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 조갑진균증 (조백선) 약물 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 조갑진균증 (조백선) 약물 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Pfizer, Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, Perrigo, Galderma pharm, Zhejiang Deyer, Valeant Pharma, Moberg
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Onychomycosis (Tinea Unguium) Drug will have significant change from previous year. By the most conservative estimates of global Onychomycosis (Tinea Unguium) Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3037.5 million in 2020. Over the next five years the Onychomycosis (Tinea Unguium) Drug market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 3834.2 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis (Tinea Unguium) Drug market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Oral Medication
External Medicine

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Age under 18
Age 18-50
Age above 50

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Market Size 2016-2026
2.1.2 Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
2.2.1 Oral Medication
2.2.2 Oral Medication
2.3 Onychomycosis (Tinea Unguium) Drug Market Size by Type
2.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Type
2.3.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2016-2021)
2.4 Onychomycosis (Tinea Unguium) Drug Segment by Application
2.4.1 Age under 18
2.4.2 Age 18-50
2.4.3 Age above 50
2.5 Onychomycosis (Tinea Unguium) Drug Market Size by Application
2.5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Application
2.5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2016-2021)

3 Onychomycosis (Tinea Unguium) Drug Market Size by Players
3.1 Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Players
3.1.1 Global Onychomycosis (Tinea Unguium) Drug Revenue by Players (2019-2021E)
3.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Players (2019-2021E)
3.2 Global Onychomycosis (Tinea Unguium) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Onychomycosis (Tinea Unguium) Drug by Regions
4.1 Onychomycosis (Tinea Unguium) Drug Market Size by Regions (2016-2021)
4.2 Americas Onychomycosis (Tinea Unguium) Drug Market Size Growth (2016-2021)
4.3 APAC Onychomycosis (Tinea Unguium) Drug Market Size Growth (2016-2021)
4.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth (2016-2021)
4.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth (2016-2021)

5 Americas
5.1 Americas Onychomycosis (Tinea Unguium) Drug Market Size by Country (2016-2021)
5.2 Americas Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021)
5.3 Americas Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Onychomycosis (Tinea Unguium) Drug Market Size by Region (2016-2021)
6.2 APAC Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021)
6.3 APAC Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Onychomycosis (Tinea Unguium) Drug by Country (2016-2021)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021)
7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug by Region (2016-2021)
8.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021)
8.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Onychomycosis (Tinea Unguium) Drug Market Forecast
10.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2021-2026)
10.1.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2021-2026)
10.1.2 Americas Onychomycosis (Tinea Unguium) Drug Forecast
10.1.3 APAC Onychomycosis (Tinea Unguium) Drug Forecast
10.1.4 Europe Onychomycosis (Tinea Unguium) Drug Forecast
10.1.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Forecast
10.2 Americas Onychomycosis (Tinea Unguium) Drug Forecast by Countries (2021-2026)
10.2.1 United States Onychomycosis (Tinea Unguium) Drug Market Forecast
10.2.2 Canada Onychomycosis (Tinea Unguium) Drug Market Forecast
10.2.3 Mexico Onychomycosis (Tinea Unguium) Drug Market Forecast
10.2.4 Brazil Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3 APAC Onychomycosis (Tinea Unguium) Drug Forecast by Region (2021-2026)
10.3.1 China Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.2 Japan Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.3 Korea Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.4 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.5 India Onychomycosis (Tinea Unguium) Drug Market Forecast
10.3.6 Australia Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4 Europe Onychomycosis (Tinea Unguium) Drug Forecast by Country (2021-2026)
10.4.1 Germany Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.2 France Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.3 UK Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.4 Italy Onychomycosis (Tinea Unguium) Drug Market Forecast
10.4.5 Russia Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Forecast by Region (2021-2026)
10.5.1 Egypt Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.2 South Africa Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.3 Israel Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.4 Turkey Onychomycosis (Tinea Unguium) Drug Market Forecast
10.5.5 GCC Countries Onychomycosis (Tinea Unguium) Drug Market Forecast
10.6 Global Onychomycosis (Tinea Unguium) Drug Forecast by Type (2021-2026)
10.7 Global Onychomycosis (Tinea Unguium) Drug Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
11.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Yangtze River
11.2.1 Yangtze River Company Information
11.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Offered
11.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Yangtze River Main Business Overview
11.2.5 Yangtze River Latest Developments
11.3 Torrent Pharma
11.3.1 Torrent Pharma Company Information
11.3.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
11.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Torrent Pharma Main Business Overview
11.3.5 Torrent Pharma Latest Developments
11.4 J&J
11.4.1 J&J Company Information
11.4.2 J&J Onychomycosis (Tinea Unguium) Drug Product Offered
11.4.3 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 J&J Main Business Overview
11.4.5 J&J Latest Developments
11.5 Chengdu Brilliant
11.5.1 Chengdu Brilliant Company Information
11.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Offered
11.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Chengdu Brilliant Main Business Overview
11.5.5 Chengdu Brilliant Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
11.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Qilu Pharmaceutical
11.7.1 Qilu Pharmaceutical Company Information
11.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
11.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Qilu Pharmaceutical Main Business Overview
11.7.5 Qilu Pharmaceutical Latest Developments
11.8 Xiuzheng Pharmaceutical
11.8.1 Xiuzheng Pharmaceutical Company Information
11.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Xiuzheng Pharmaceutical Main Business Overview
11.8.5 Xiuzheng Pharmaceutical Latest Developments
11.9 Hubei Hengan
11.9.1 Hubei Hengan Company Information
11.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Offered
11.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Hubei Hengan Main Business Overview
11.9.5 Hubei Hengan Latest Developments
11.10 TARO
11.10.1 TARO Company Information
11.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Offered
11.10.3 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 TARO Main Business Overview
11.10.5 TARO Latest Developments
11. Perrigo
11.11.1 Perrigo Company Information
11.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Offered
11.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Perrigo Main Business Overview
11.11.5 Perrigo Latest Developments
11.12 Galderma pharm
11.12.1 Galderma pharm Company Information
11.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Offered
11.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Galderma pharm Main Business Overview
11.12.5 Galderma pharm Latest Developments
11.13 Zhejiang Deyer
11.13.1 Zhejiang Deyer Company Information
11.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Offered
11.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Zhejiang Deyer Main Business Overview
11.13.5 Zhejiang Deyer Latest Developments
11.14 Valeant Pharma
11.14.1 Valeant Pharma Company Information
11.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
11.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Valeant Pharma Main Business Overview
11.14.5 Valeant Pharma Latest Developments
11.15 Moberg
11.15.1 Moberg Company Information
11.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Offered
11.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Moberg Main Business Overview
11.15.5 Moberg Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral Medication
Table 3. Major Players of External Medicine
Table 4. Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2016-2021)
Table 7. Onychomycosis (Tinea Unguium) Drug Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2016-2021)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Players (2019-2021E)
Table 12. Onychomycosis (Tinea Unguium) Drug Key Players Head office and Products Offered
Table 13. Onychomycosis (Tinea Unguium) Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Onychomycosis (Tinea Unguium) Drug Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Regions 2016-2021
Table 18. Americas Onychomycosis (Tinea Unguium) Drug Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country (2016-2021)
Table 20. Americas Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2016-2021)
Table 22. Americas Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2016-2021)
Table 24. APAC Onychomycosis (Tinea Unguium) Drug Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region (2016-2021)
Table 26. APAC Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2016-2021)
Table 28. APAC Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2016-2021)
Table 30. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country (2016-2021)
Table 32. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2016-2021)
Table 34. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Onychomycosis (Tinea Unguium) Drug
Table 43. Key Application and Potential Industries of Onychomycosis (Tinea Unguium) Drug
Table 44. Key Challenges of Onychomycosis (Tinea Unguium) Drug
Table 45. Key Trends of Onychomycosis (Tinea Unguium) Drug
Table 46. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share Forecast by Application (2021-2026)
Table 52. Pfizer Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 53. Pfizer Onychomycosis (Tinea Unguium) Drug Product Offered
Table 54. Pfizer Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Yangtze River Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 58. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Offered
Table 59. Yangtze River Main Business
Table 60. Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Yangtze River Latest Developments
Table 62. Torrent Pharma Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 63. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 64. Torrent Pharma Main Business
Table 65. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Torrent Pharma Latest Developments
Table 67. J&J Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 68. J&J Onychomycosis (Tinea Unguium) Drug Product Offered
Table 69. J&J Main Business
Table 70. J&J Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. J&J Latest Developments
Table 72. Chengdu Brilliant Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 73. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Offered
Table 74. Chengdu Brilliant Main Business
Table 75. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Chengdu Brilliant Latest Developments
Table 77. Novartis Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 78. Novartis Onychomycosis (Tinea Unguium) Drug Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Novartis Latest Developments
Table 82. Qilu Pharmaceutical Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 83. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 84. Qilu Pharmaceutical Main Business
Table 85. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Qilu Pharmaceutical Latest Developments
Table 87. Xiuzheng Pharmaceutical Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 88. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Offered
Table 89. Xiuzheng Pharmaceutical Main Business
Table 90. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Xiuzheng Pharmaceutical Latest Developments
Table 92. Hubei Hengan Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 93. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Offered
Table 94. Hubei Hengan Main Business
Table 95. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Hubei Hengan Latest Developments
Table 97. TARO Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 98. TARO Onychomycosis (Tinea Unguium) Drug Product Offered
Table 99. TARO Main Business
Table 100. TARO Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. TARO Latest Developments
Table 102. Perrigo Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 103. Perrigo Onychomycosis (Tinea Unguium) Drug Product Offered
Table 104. Perrigo Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Perrigo Main Business
Table 106. Perrigo Latest Developments
Table 107. Galderma pharm Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 108. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Offered
Table 109. Galderma pharm Main Business
Table 110. Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Galderma pharm Latest Developments
Table 112. Zhejiang Deyer Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 113. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Offered
Table 114. Zhejiang Deyer Main Business
Table 115. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. Zhejiang Deyer Latest Developments
Table 117. Valeant Pharma Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 118. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Offered
Table 119. Valeant Pharma Main Business
Table 120. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Valeant Pharma Latest Developments
Table 122. Moberg Details, Company Type, Onychomycosis (Tinea Unguium) Drug Area Served and Its Competitors
Table 123. Moberg Onychomycosis (Tinea Unguium) Drug Product Offered
Table 124. Moberg Main Business
Table 125. Moberg Onychomycosis (Tinea Unguium) Drug Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Moberg Latest Developments
List of Figures
Figure 1. Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2020
Figure 7. Onychomycosis (Tinea Unguium) Drug in Age under 18
Figure 8. Global Onychomycosis (Tinea Unguium) Drug Market: Age under 18 (2016-2021) & ($ Millions)
Figure 9. Onychomycosis (Tinea Unguium) Drug in Age 18-50
Figure 10. Global Onychomycosis (Tinea Unguium) Drug Market: Age 18-50 (2016-2021) & ($ Millions)
Figure 11. Onychomycosis (Tinea Unguium) Drug in Age above 50
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Market: Age above 50 (2016-2021) & ($ Millions)
Figure 13. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2020
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Player in 2020
Figure 15. Global Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Onychomycosis (Tinea Unguium) Drug Market Size 2016-2021 ($ Millions)
Figure 17. APAC Onychomycosis (Tinea Unguium) Drug Market Size 2016-2021 ($ Millions)
Figure 18. Europe Onychomycosis (Tinea Unguium) Drug Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size 2016-2021 ($ Millions)
Figure 20. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country in 2020
Figure 21. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2020
Figure 22. Americas Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2020
Figure 23. United States Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Regions in 2020
Figure 27. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2020
Figure 28. APAC Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2020
Figure 29. China Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Country in 2020
Figure 36. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2020
Figure 37. Europe Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2020
Figure 38. Germany Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Market Share by Application in 2020
Figure 46. Egypt Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Onychomycosis (Tinea Unguium) Drug Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 52. APAC Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 53. Europe Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 55. United States Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 56. Canada Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 59. China Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 60. Japan Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 61. Korea Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 63. India Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 64. Australia Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 65. Germany Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 66. France Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 67. UK Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 68. Italy Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 69. Russia Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 70. Spain Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 73. Israel Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Onychomycosis (Tinea Unguium) Drug Market Size 2021-2026 ($ Millions)
※본 조사보고서 [세계의 조갑진균증 (조백선) 약물 시장예측 2021년-2026년] (코드 : LPI-2201K02117) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 조갑진균증 (조백선) 약물 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!